Business Context and Reporting Period
Company: U.S. Auto Parts Network, Inc. (d/b/a Carparts.Com, Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: October 8, 2014
Event: Entry into a Material Definitive Agreement involving the financing of its subsidiary, AutoMD, Inc.
Key Financial Metrics and Transaction Details
- Financing Amount: $7,000,000 raised through the sale of 7,000,000 shares of AutoMD common stock at $1.00 per share.
- Ownership Structure: Following the transaction, the Company holds approximately 64.1% of AutoMD's outstanding common stock; AutoMD is no longer a wholly-owned subsidiary.
- Debt Facility Amendment: Revolving credit commitment with JPMorgan Chase Bank, N.A. increased from $20,000,000 to $25,000,000.
- Contingent Obligations:
- Second Closing: Potential obligation to purchase an additional 2,000,000 shares of AutoMD stock ($2,000,000) if AutoMD fails to meet specific cash balance and shop approval targets within two years.
- IP Reimbursement: Agreement to reimburse AutoMD for legal expenses related to intellectual property up to a maximum of $2,500,000.
Material Changes and Agreements
The filing details the execution of several definitive agreements on October 8, 2014:
- Common Stock Purchase Agreement: Sold equity to Muzzy-Lyon Auto Parts, Inc., Manheim Investments, Inc., Oak Investment Partners XI, L.P., and the Sol Khazani Living Trust.
- Investor Rights Agreement: Grants investors registration rights, information rights, and pro rata purchase rights for future issuances. Includes a three-year restriction on the Company selling AutoMD stock below 50% ownership without consent, with a repurchase option at $1.00 per share plus 10% annual interest if consent is denied.
- Voting Agreement: Establishes board composition with three directors designated by the Company, one by Oak, and potential designees by Muzzy-Lyon and Manheim.
- Co-Sale Agreement: Provides investors with rights of first refusal and co-sale rights regarding the transfer of AutoMD stock.
Guidance, Risks, and Contingencies
Liquidity and Financial Covenants: The Company's ability to fulfill obligations under the financing documents (including the Second Closing, IP Reimbursement, and repurchase options) is contingent upon meeting specific financial tests:
- Second Closing & IP Reimbursement: Requires excess borrowing availability of at least $4,000,000 under the Credit Agreement. The Second Closing also requires a minimum fixed charge coverage ratio of 1.25:1.0.
- Repurchase Options (Restricted Transfer/AutoMD Repurchase): Requires excess borrowing availability of at least $6,000,000 and a minimum fixed charge coverage ratio of 1.25:1.0.
Risks: The Company faces potential cash outflows if AutoMD fails to meet performance metrics or if investors exercise repurchase rights. Additionally, the Company is restricted from selling AutoMD below 50% ownership or engaging in strategic transactions involving AutoMD for three years without investor consent.
Investor Verification Checklist
- Verify the current excess borrowing availability under the amended Credit Agreement to assess the ability to fund the contingent $2,000,000 Second Closing and potential $2,500,000 IP reimbursement.
- Confirm the current fixed charge coverage ratio to ensure compliance with the 1.25:1.0 threshold required for contingent obligations.
- Review the specific performance metrics (cash balances and approved auto repair shop numbers) AutoMD must meet to avoid triggering the Second Closing purchase obligation.
- Assess the impact of the 64.1% ownership stake on consolidated financial reporting and potential future dilution.